AB Amara

AB Amara

University of Liverpool

H-index: 19

Europe-United Kingdom

About AB Amara

AB Amara, With an exceptional h-index of 19 and a recent h-index of 14 (since 2020), a distinguished researcher at University of Liverpool, specializes in the field of Clinical Pharmacology, Clinical Nephrology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC–MS

Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021

An open label, adaptive, phase 1 trial of high‐dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS‐CoV‐2

Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019

Clinical Trials Registration. NCT04746183.

2022 Index IEEE Transactions on Biomedical Engineering Vol. 69

SALIVA, NASAL & TEAR PK of EIDD-1931 in PATIENTS with COVID-19 RECEIVING MOLNUPIRAVIR

Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in nonplasma compartments of patients with severe acute respiratory syndrome …

AB Amara Information

University

University of Liverpool

Position

___

Citations(all)

972

Citations(since 2020)

570

Cited By

620

hIndex(all)

19

hIndex(since 2020)

14

i10Index(all)

30

i10Index(since 2020)

25

Email

University Profile Page

University of Liverpool

AB Amara Skills & Research Interests

Clinical Pharmacology

Clinical Nephrology

Top articles of AB Amara

Title

Journal

Author(s)

Publication Date

Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC–MS

Bioanalysis

Beth Thompson

Sujan Dilly-Penchala

Alieu Amara

Helen Reynolds

Saye Khoo

...

2023/7

Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021

Eurosurveillance

Victoria Maddox

Claire Reynolds

Alieu Amara

Laura Else

Susan R Brailsford

...

2023/3/16

An open label, adaptive, phase 1 trial of high‐dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS‐CoV‐2

Clinical Pharmacology & Therapeutics

Lauren E Walker

Richard FitzGerald

Geoffrey Saunders

Rebecca Lyon

Michael Fisher

...

2022/3

Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019

Sexually Transmitted Infections

Heli Harvala

Claire Reynolds

Samreen Ijaz

Vicki Maddox

Sujan Dilly Penchala

...

2022/3/1

Clinical Trials Registration. NCT04746183.

Richard FitzGerald

Laura Dickinson

Laura Else

Thomas Fletcher

Colin Hale

...

2022

2022 Index IEEE Transactions on Biomedical Engineering Vol. 69

IEEE Transactions on Biomedical Engineering

B Aazhang

SF Abbasi

Z Abbasi

T Abbasiasl

A Abbosh

...

2022/12

SALIVA, NASAL & TEAR PK of EIDD-1931 in PATIENTS with COVID-19 RECEIVING MOLNUPIRAVIR

Topics in Antiviral Medicine

R FitzGerald

L Dickinson

L Else

T Fletcher

C Hale

...

2022

Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in nonplasma compartments of patients with severe acute respiratory syndrome …

Clinical Infectious Diseases

Richard FitzGerald

Laura Dickinson

Laura Else

Thomas Fletcher

Colin Hale

...

2022/7/1

The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva

Journal of pharmaceutical and biomedical analysis

Alieu Amara

Sujan Dilly Penchala

Laura Else

Colin Hale

Richard FitzGerald

...

2021/11/30

Infant exposure to dolutegravir through placental and breast milk transfer: a population pharmacokinetic analysis of DolPHIN-1

Clinical Infectious Diseases

Laura Dickinson

Stephen Walimbwa

Yashna Singh

Julian Kaboggoza

Kenneth Kintu

...

2021/9/1

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)

Journal of Antimicrobial Chemotherapy

Carolina Herrera

Julianne Lwanga

Ming Lee

Suna Mantori

Alieu Amara

...

2021/8/1

An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2 (preprint)

Lauren E Walker

Richard FitzGerald

Geoffrey Saunders

Rebecca Lyon

Michael Fisher

...

2021

Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry

Wellcome open research

Adeniyi Olagunju

Jacinta Nwogu

Oluwasegun Eniayewu

Shakir Atoyebi

Alieu Amara

...

2021

2021 Index IEEE Transactions on Biomedical Circuits and Systems Vol. 15

IEEE Transactions on Biomedical Circuits and Systems

Y Abbass

A Abbosh

SM Abubakar

J Acevedo

J Adegite

...

2021/12

The development and validation of a novel LC–MS/MS method for the quantification of c enicriviroc in human plasma and cerebrospinal fluid

Biomedical Chromatography

Sujan Dilly Penchala

Jasmini Alagaratnam

Elizabeth Challenger

Alieu Amara

Laura Else

...

2020/1

See List of Professors in AB Amara University(University of Liverpool)

AB Amara FAQs

What is AB Amara's h-index at University of Liverpool?

The h-index of AB Amara has been 14 since 2020 and 19 in total.

What are AB Amara's top articles?

The articles with the titles of

Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC–MS

Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021

An open label, adaptive, phase 1 trial of high‐dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS‐CoV‐2

Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019

Clinical Trials Registration. NCT04746183.

2022 Index IEEE Transactions on Biomedical Engineering Vol. 69

SALIVA, NASAL & TEAR PK of EIDD-1931 in PATIENTS with COVID-19 RECEIVING MOLNUPIRAVIR

Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in nonplasma compartments of patients with severe acute respiratory syndrome …

...

are the top articles of AB Amara at University of Liverpool.

What are AB Amara's research interests?

The research interests of AB Amara are: Clinical Pharmacology, Clinical Nephrology

What is AB Amara's total number of citations?

AB Amara has 972 citations in total.